Bicycle Therapeutics (BCYC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bicycle Therapeutics

    NASDAQ: BCYC · Real-Time Price · USD
    7.40
    -0.14 (-1.86%)
    At close: Sep 26, 2025, 3:59 PM
    7.54
    1.89%
    After-hours: Sep 26, 2025, 05:16 PM EDT

    Bicycle Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 35.27M 26.98M 14.46M 11.7M
    Cost of Revenue
    		 172.97M 156.5M 3.69M 44.88M
    Gross Profit
    		 -137.69M -129.52M -67.15M -33.18M
    Operating Income
    		 -209.87M -189.95M -116.65M -65.62M
    Interest Income
    		 34.28M 14M 5.76M 120K
    Pretax Income
    		 -173.8M -179.21M -114.24M -68.48M
    Net Income
    		 -169.03M -180.66M -112.72M -66.82M
    Selling & General & Admin
    		 71.46M 59.83M 49.51M 32.44M
    Research & Development
    		 172.97M 156.5M 81.61M 44.88M
    Other Expenses
    		 -172.25M -155.9M -81.61M n/a
    Operating Expenses
    		 72.18M 60.43M 49.51M 77.31M
    Interest Expense
    		 1.73M 3.26M 3.34M 2.98M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 245.15M 216.92M 131.12M 77.31M
    Income Tax Expense
    		 -4.76M 1.46M -1.52M -1.66M
    Shares Outstanding (Basic)
    		 58.21M 35.59M 29.66M 25.06M
    Shares Outstanding (Diluted)
    		 58.21M 35.59M 29.66M 25.06M
    EPS (Basic)
    		 -2.91 -5.08 -3.8 -2.67
    EPS (Diluted)
    		 -2.9 -5.08 -3.8 -2.67
    EBITDA
    		 -164.89M -183.4M -112.96M -64.08M
    EBIT
    		 -172.07M -189.95M -116.65M -65.5M
    Depreciation & Amortization
    		 7.18M 6.55M 3.69M 1.41M

    Add to Watchlist